Effects of different exercise modes on mineralization, structure, and biomechanical properties of growing bone

Weight bearing during exercise plays an important role in improving the mechanical properties of bone. The effect on bone of non-weight-bearing exercise such as swimming remains controversial. To investigate the effects of exercise mode on growing bone, 29 male Wistar rats (7 wk old) were randomly assigned to a running exercise group (Run, n = 9), a swimming exercise group (Swim, n = 10), or a nonexercise control group (Con, n = 10). During an 8-wk training session (20-60 min/day, 5 days/wk), the Run rats were trained at progressively increasing running speeds (12-22 m/min), and weights attached to the tail of the Swim rats were progressively increased from 0 to 2% of their body weight. The bone mineral density of the proximal tibiae of the Run rats was significantly higher than in the Swim (P < 0.05). Femoral wet weights of the two exercise groups were significantly higher than in the control group (P < 0.05). Interestingly, the percent difference between the tissue wet weight and dry weight (water content ratio), which is related to bone mechanical properties, was significantly higher in the tibiae of the Swim rats and the femora of both exercise groups compared with controls (P < 0.05). Extrinsic as well as intrinsic biomechanical material properties were measured in a three-point bending test. Bone mechanical properties of the tibiae and femora of rats in the Swim and Run groups were significantly greater than those in the control group (P < 0.05). In summary, different modes of exercise may benefit bone mechanical properties in different ways. The specific effects of swimming exercise (non-weight-bearing exercise) on bone require further study.

Effects of caffeine and exercise on the development of bone: a densitometric and histomorphometric study in young Wistar rats

High doses of caffeine will induce calcium loss and influence the normal development of bone, whereas the proper exercise has positive effects on bone metabolism. This study investigated the possible effects of exercise to antagonize the caffeine-induced impairment of bone development in young male Wistar rats. A total of 32 male rats (5 weeks old) were divided randomly into four groups: group 1 rats were fed caffeine; group 2 rats were prescribed an exercise program; group 3 rats were fed caffeine and prescribed an exercise program; and group 4 rats served as the control group. The caffeine was fed via the animals' dietary water and the dosage was 10 mg/100 g body weight per day, 3 days a week. The exercise program was carried out on a treadmill for 10 weeks (5 days/week, 1 h/day, 70% VO(2)max). Body weight was measured weekly. After sacrifice, the tibia length was measured and the tibia was processed for histomorphometric analysis. Bone mineral density was measured by dual-energy X-ray absorptiometer at three different sites of the tibia. In addition, the calcium content of the right femur was measured by atomic absorptiometry. The results showed that both exercise and caffeine significantly lowered the body weight gain. Rats fed with caffeine (groups 1 and 3) had a significantly longer tibia as compared with the non-caffeine-fed rats (groups 2 and 4) (p = 0.0149). The histomorphometry study showed that thickness of the growth plate in the proliferative zone, the hypertrophic zone, and total growth plate was greater in caffeine-fed groups than in non-caffeine-fed groups. The cell number in the proliferative zone was higher in the caffeine-fed groups. Area ratio of trabeculae in the primary spongiosa of rats in groups 1 and 2 were significantly greater than the control group. Caffeine feeding (groups 1 and 3) induced a lower area ratio of bone trabeculae in the secondary spongiosa, whereas exercise training (groups 2 and 3) increased the thickness of the trabeculae. The exercise program counteracted the negative effect of caffeine on the trabecular thickness, but did not correct the trabecular bone ratio. The bone mineral density (BMD) of the tibia was significantly lower in caffeine-fed rats, and the exercise program did not show any counteracting effect on the caffeine-induced BMD reduction. The calcium content assay showed that caffeine feeding decreased the weight and total calcium content of the femur. Again this exercise program did not counterbalance the negative effects of caffeine. In conclusion, high doses of caffeine seemed to stimulate the growth of long bone. However, it caused more serious negative effects on bone, including bone mineral loss, lower BMD, and lower calcium content. Exercise training at 70% VO(2)max had little antagonizing effect on caffeine-induced impairment of bone formation. Therefore, the best way to prevent caffeine-induced negative effects on bone development is to lower caffeine exposure.

Effects of a 7-day eccentric training period on muscle damage and inflammation

PURPOSE

This study examined the effects of a 7-d repeated maximal isokinetic eccentric training period on the indicators of muscle damage and inflammatory response.

METHODS

Twenty-two college-age males were randomly assigned to eccentric training (ET) (N = 12) and control groups (CON) (N = 10). The initial exercise was 30 repetitions of maximal voluntary isokinetic eccentric contraction (ECC1) on nondominant elbow flexors with Cybex 6000 at 60 degrees.s-1 angular velocity. The ET group performed the same exercise for the following 6 consecutive days (referred to as ECC2 to ECC7) after ECC1. Upper arm circumference (CIR), range of motion (ROM), and maximal isometric force (MIF) were measured before, immediately after, and every 24 h for 7 consecutive days after ECC1. Plasma creatine kinase (CK), lactate dehydrogenase (LDH), glutamic oxaloacetate transaminase (GOT), leukocyte counts, and serum interleukin-1beta and -6 (IL-1beta, IL-6) levels were assessed before; at 2 h; and at 1, 3, 4, 6, and 7 d after ECC1. Muscle soreness was measured before and for 7 consecutive days after ECC1.

RESULTS

The ECC1 produced significant changes in most of the measures for both groups (P < 0.05), with the exception of leukocyte counts (P > 0.05). No indicators of increased damage (P > 0.05) were found from ECC2 to ECC7 for the ET group.

CONCLUSION

Continuous intensive isokinetic eccentric training performed with damaged muscles did not exacerbate muscle damage and inflammation after ECC1. In addition, a muscular "adaptation effect" may occur as early as 24 h after ECC1, as shown by the ET group's performance for 6 consecutive days after ECC1.

The effects of repeated maximal voluntary isokinetic eccentric exercise on recovery from muscle damage

This study investigated whether performing repeated bouts of maximal voluntary isokinetic eccentric exercise (MAX1) on 3 (MAX3) and 6 days (MAX6) after the initial bout would produce significant changes in the indirect markers of muscle damage and total work. A secondary purpose was to determine whether participants' psychological maximal effort was equivalent to the physiological maximal effort during muscle soreness. Male university students were assigned randomly to a control group (n = 12) and a group that repeated the exercise (EX; n = 12). The MAX1 was 3 x 10 repetitions of the nondominant elbow flexors on the Cybex 6000 system at a speed of 60 deg/s. The EX group performed the same exercise 3 days and 6 days after MAX1. The range of motion and maximal isometric force (MIF), muscle soreness index, plasma creatine kinase, and glutamic-oxaloacetate transaminase activities were measured before and every 24 hr for 9 days after MAX1 for both groups. MIF was also assessed once before and immediately after each MAX for the EX group. There were no significant changes (p > .05) between the groups for all criterion measures, except for total amount of work (p < .05). It is concluded that strenuous voluntary isokinetic eccentric exercise performed with damaged muscles does not appear to exacerbate damage or influence the recovery process. Although individuals could perform repeated MAXs, the total work performed was significantly reduced. This has practical implications in strength training for coaches and athletes during muscle damage.

ERbB-2 expression is rate-limiting for epidermal growth factor-mediated stimulation of ovarian cancer cell proliferation

Over-expression of the ErbB-2 proto-oncogene frequently coincides with an aggressive clinical course of certain human adenocarcinomas. The ErbB-2 receptor is a member of the ErbB family of growth factor receptors, and within this complex signaling network, ErbB-2-containing heterodimers are preferentially formed. To assess whether ErbB-2 is a critical component in epidermal growth factor (EGF)-mediated stimulation of tumor cell proliferation, we used as a model SK-OV-3 ovarian cancer cells, which over-express EGF receptor (EGFR) and ErbB-2 receptors. In these cells, we reduced ErbB-2 mRNA and protein expression by transfection with ErbB-2-targeted hammerhead ribozymes and generated cell lines expressing different levels of ErbB-2. In SK-OV-3 cells, ErbB-2 expression conferred a growth advantage and soft agar experiments revealed that ErbB-2 was rate-limiting for anchorage-independent growth. The induction of colony formation by EGF was completely abrogated in ErbB-2-depleted cells, despite unchanged expression levels and tyrosine phosphorylation of the EGFR. The duration of EGF-mediated c-Fos mRNA up-regulation was decreased in parallel with loss of ErbB-2 expression. Furthermore, the rate of spontaneous apoptosis was increased in ErbB-2-depleted cells. Our results demonstrate that in human ovarian cancer cells the EGFR-ErbB-2 heterodimer, and not the EGFR homodimer, can be rate-limiting for EGF-mediated proliferation, thus suggesting that the oncogenic activity of ErbB-2 in human tumors is due in part to its ability to increase the growth response to stroma-derived EGF-like growth factors.

Reversal of HER-2 over-expression renders human ovarian cancer cells highly resistant to taxol

Currently, the treatment options for advanced ovarian cancer are limited. Thus, the majority of the patients are treated with drugs with considerable side effects but in many cases without clinical benefit. The relationship between activation of an oncogene like the HER-2 receptor and drug sensitivity, is of considerable interest as this molecular marker may allow to better predict response to chemotherapy. The aim of this study was to evaluate whether over-expression of the HER-2 receptor would modulate drug responsiveness to doxorubicin, cisplatin and taxol in ovarian cancer cells. An anti-HER-2-targeted ribozyme approach was used to abrogate HER-2 expression in human SK-OV-3 ovarian cancer cells. SK-OV-3 cells expressing very low residual levels of HER-2 protein, were then assessed for their sensitivity to doxorubicin, cisplatin and taxol and compared to control cells. HER-2 expression had no effect on the cytotoxicity of doxorubicin (IC50=10 nM) or cisplatin (IC50=5 microM) in proliferation assays. In contrast, the sensitivity to taxol was increased approximately 70-fold in SK-OV-3 ovarian cancer cells expressing high levels of HER-2 (IC50=10(-5) nM) compared to HER-2 depleted cells (IC50=7x10(-4) nM). If these findings can be confirmed in patients, it could be possible that HER-2 expression may serve as a marker for response to taxol treatment in ovarian cancer patients.

Adenovirus-mediated transduction of ribozymes abrogates HER-2/neu and pleiotrophin expression and inhibits tumor cell proliferation

The combination of specific gene targeting technologies with efficient gene delivery systems could provide the means to evaluate the concept of anticancer strategies designed to block expression of potentially rate-limiting tumor promoting factors. Here, we constructed adenoviruses expressing hammerhead-ribozymes targeted to two of these factors, the tyrosine kinase receptor HER-2/neu or the growth factor pleiotrophin (PTN). Adenovirus-mediated transduction of either HER-2/neu- or PTN-targeted ribozymes depleted the respective RNAs and inhibited protein expression significantly in three different human cancer cell lines. This resulted in almost complete abrogation of HER-2/neu- or PTN-dependent cancer-cell proliferation, thus demonstrating the feasibility of this approach as a future cancer gene therapy.

Molecular and pharmacologic targeting of angiogenesis factors--the example of pleiotrophin

Polypeptide growth factors contribute to the development and maintenance of normal tissues and are essential for the growth and metastasis of solid tumors. During tumor progression these factors function as autocrine stimulators of tumor cells and/or serve to recruit stromal tissue and blood supply to the expanding tumor. In particular, tumor-induced angiogenesis appears to be significant not only for local tumor growth but also for metastasis to distant organ sites. We purified several years ago the heparin-binding growth factor pleiotrophin (PTN) from the supernatants of human breast cancer cells and demonstrated that PTN can serve as an angiogenesis factor. We found the gene expressed in a number of human tumor cell lines as well as in human tumor tissues. Here we present different approaches to inhibit production and function of this growth factor. Finally we discuss how the experience from this growth factor can be applied to improve our understanding of the role of other factors thought to contribute to tumor angiogenesis.

Additive effects of caffeine and cold water during submaximal leg exercise

Ten males exercised for 55 min at 1.5 W.kg-1 in 28 degrees C and 18 degrees C water to determine whether cold water plus caffeine (CF) ingestion had additive effects on energy production or core temperature. Two immersions were done at each water temperature, once with CF (5 mg.kg-1) and once with placebo (PL). Cold water alone (28 PL vs 18 PL) decreased free fatty acid (FFA, -13 +/- 8%) and glycerol (-37 +/- 15%) and increased lactate (18 +/- 12%), VO2 (11 +/- 3%), and minute ventilation (VE, 8 +/- 4%) but did not change glucose, heart rate (HR), respiratory exchange ratio (RER), or rectal temperature. CF alone (28 PL vs 28 CF) increased FFA (52 +/- 18%), glycerol (14 +/- 8%), lactate (28 +/- 10%), VO2 (9 +/- 3%), VE (7 +/- 5%), HR (4 +/- 1%), and rectal temperature (2 +/- 0.4%) but did not alter RER. Significant additive effects of cold water + CF (28 PL vs 18 CF) were noted for FFA, glycerol, lactate, VO2, and VE but not for RER and rectal temperature. These findings indicate that additive effects of cold water + CF alter substrate availability and increase energy production, but without a change in lipid utilization or core temperature. It may be concluded that use of CF during exercise in cold water has no physiological benefit.

Exercise intensity and erythrocyte 2,3-diphosphoglycerate concentration

The present study examines the acute effects of two different exercise intensities on erythrocyte 2,3-diphosphoglycerate (2,3-DPG) concentration. Thirty-one females (X +/- SD age = 23.7 +/- 3.37 yr; VO2max = 44.3 +/- 5.40 ml X kg-1 X min-1) completed 2 separate 15-min constant load cycling tests at exercise intensities representing 35 and 75% of VO2max. Venous blood was obtained pre-exercise (PRE), immediately post-exercise (POST), 15 min post-exercise (POST15), and 30 min post-exercise (POST30) to determine lactic acid, 2,3-DPG, and hemoglobin concentrations and hematocrit. Significant increases (P less than 0.01) in lactic acid concentration (1.1 +/- 0.14 at PRE to 6.2 +/- 0.48 m X mol-1 X l-1 at POST), 2,3-DPG concentration (1.9 +/- 0.06 at PRE to 2.1 +/- 0.06 mumol X ml-1 at POST), and 2,3-DPG corrected for plasma volume shift (PVC 2,3-DPG) (1.9 +/- 0.06 at PRE to 2.4 +/- 0.07 mumol X ml-1 at POST15) were observed only following the 75% submaximal exercise. At POST30 (75% VO2max) PVC 2,3-DPG and lactic acid remained 5.3 and 97% (P less than 0.05) above baseline, respectively. An exercise intensity effect was observed only in lactic acid response (P less than 0.05) but not in 2,3-DPG (mumol X ml-1 and mumol X g-1 hemoglobin or PVC 2,3-DPG. A significant time-intensity interaction (P less than 0.05) for PVC 2,3-DPG suggests that PVC 2,3-DPG response over time was different between the two exercise intensity levels, with the 75% intensity eliciting a greater increase in PVC 2,3-DPG.(ABSTRACT TRUNCATED AT 250 WORDS)

Delayed onset muscle soreness following repeated bouts of downhill running

Perceived muscle soreness ratings, serum creatine kinase (CK) activity, and myoglobin levels were assessed in three groups of subjects following two 30-min exercise bouts of downhill running (-10 degrees slope). The two bouts were separated by 3, 6, and 9 wk for groups 1, 2, and 3, respectively. Criterion measures were obtained pre- and 6, 18, and 42 h postexercise. On bout 1 the three groups reported maximal soreness at 42 h postexercise. Also, relative increases in CK for groups 1, 2, and 3 were 340, 272, and 286%, respectively. Corresponding values for myoglobin were 432, 749, and 407%. When the same exercise was repeated, significantly less soreness was reported and smaller increases in CK and myoglobin were found for groups 1 and 2. For example, the percent CK increases on bout 2 for groups 1 and 2 were 63 and 62, respectively. Group 3 demonstrated no significant difference in soreness ratings, CK activities, or myoglobin levels between bouts 1 and 2. It was concluded that performance of a single exercise bout had a prophylactic effect on the generation of muscle soreness and serum protein responses that lasts up to 6 wk.

The acute effects of controlled breathing swimming on glycolytic parameters

Hypoxic Training, which has been popular in swimming for the past few years, is more correctly called Controlled Breathing Swimming (CBS). This study investigated the acute effects of CBS on blood glucose (GL), lactate (LA), pH, PvCO2, and recovery oxygen uptake. Six male swimmers were studied in two separate swimming sessions using two breathing patterns--free breathing (FB), and 7-stroke breathing (7B). For each session venous blood samples were drawn prior to the swim (Rest), immediately after the swim (IA), and during the 6th minute of recovery (6-R). Analyses for GL, LA, pH, and PvCO2 were carried out, and recovery VO2 (20 minutes) was calculated. Significant increased due to the exercise sessions themselves were found in both GL (p less than 0.05), and LA (p less than 0.05) concentrations. Between the two swim protocols, no significant difference was observed except for a significantly greater % CO2 production after the 7B swim (p less than 0.05). These results indicated that the acute CBS did not induce more glycolytic metabolic activity than did the normal swimming protocol.